Next-Generation Sequencing Market Industry: A Latest Research Report to Share Market Insights, Dynamics and Key Players: Illumina, Applied Biosystems (ABI), Roche (454), Helicos, LifeTechnologies

Introduction of advanced and rapid sequencing technologies for clinical processes is expected to drive the market. The advancement in the bioinformatics field also drive the adoption of NGS platforms in diagnosis and analysis of rare diseases, identifying therapeutic targets, and for prenatal testing. Over the forecast period, NGS methodologies are expected to witness high demand in clinical diagnosis, genomics research, and in the precision treatment of varied diseases.

Get a Free Sample here: https://www.worldwidemarketreports.com/sample/264858

Market Segment by Companies, this report covers Illumina, Applied Biosystems (ABI), Roche (454), Helicos, LifeTechnologies

Moreover, due to rapid development of companion diagnostics in delivering advanced genomic and personalised medicine, is poised to fuel the market growth in the near future. Advent of targeted therapies in oncology and other fields has significantly transformed the companion diagnostics. The NGS techniques are likely to help expand the companion diagnostics vertical, as NGS panels are capable of measuring several bio markers in one test. Consequently, this makes the NGS method as ideal targeted therapies in delivering precision medicine.

Oncology was the key application segment in 2019. With the rapid expansion of NGS capabilities, it is possible to sequence multiple genomes simultaneously and targeted sequencing of several cancer genes, consequently allowing the oncologists to access genetic information present in gene clusters related to tumour cells and cancer.

North America was the key regional market in 2019 and will expand further due to simultaneous developments of NGS, precision medicine, and companion diagnostics. As these biotechnology sectors are capital-intensive, high R&D investment in the region complement the inter-related development of these sectors. Moreover, majority of the academic research centres, hospitals, and clinics using NGS products and services are located in U.S.

Get Discount on This Research Report: https://www.worldwidemarketreports.com/discount/264858

Strong presence of prominent firms, such as Roche Holding AG, contributes to the introduction of rapid and high throughput sequencing capabilities, thereby boosting the market growth. Asia Pacific is also projected to have a lucrative growth due to significant developments initiated by key companies for technological integration of NGS methodologies. For instance, in January 2019, Illumina, Inc. collaborated with KingMed Diagnostics to utilise Illumina’s NGS technology for oncology and hereditary disease testing.

For Full TOC and Detailed information on all Key Players Place an Inquire: https://www.worldwidemarketreports.com/quiry/264858

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Email:sales@worldwidemarketreports.com

This release was published on openPR.